Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person SU drugs bind ABCC8 (in KCNJ11 tetramer:ABCC8:Mg2+:ADP tetramer)

Class:IdReaction:9652580
_displayNameSU drugs bind ABCC8 (in KCNJ11 tetramer:ABCC8:Mg2+:ADP tetramer)
_doReleaseTRUE
_timestamp2022-08-19 04:05:12
authored[InstanceEdit:9724665] Jassal, Bijay, 2021-03-25
compartment[Compartment:984] extracellular region
[Compartment:876] plasma membrane
created[InstanceEdit:9652540] Jassal, Bijay, 2019-07-01
definitionInhibition
edited[InstanceEdit:9757169] Jassal, Bijay, 2021-10-27
[InstanceEdit:9773839] Matthews, Lisa, 2022-05-10
input[Complex:265734] KCNJ11 tetramer:ABCC8:Mg2+:ADP tetramer [plasma membrane] [Homo sapiens]
[DefinedSet:9652588] SU drugs [extracellular region]
isChimericFALSE
literatureReference[LiteratureReference:9652614] Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels
[LiteratureReference:9652546] The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation
[LiteratureReference:9652616] Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel
[LiteratureReference:9652574] Sulfonylurea stimulation of insulin secretion
[LiteratureReference:9652597] Studies on the mechanism of tolbutamide hypoglycemia in animal and human subjects
[LiteratureReference:9652550] The tolbutamide site of SUR1 and a mechanism for its functional coupling to K(ATP) channel closure
[LiteratureReference:9652619] Molecular action of sulphonylureas on KATP channels: a real partnership between drugs and nucleotides
[LiteratureReference:9652587] Individual sulfonylureas and serious hypoglycemia in older people
[LiteratureReference:9652586] Clinical experience with the oral antidiabetic compound, tolazamide
[LiteratureReference:9652559] Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus
[LiteratureReference:9652556] Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents
[LiteratureReference:9652565] Clinical pharmacology of glipizide
[LiteratureReference:9652575] Gliclazide modified release: from once-daily administration to 24-hour blood glucose control
[LiteratureReference:9652600] GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients
[LiteratureReference:9652602] A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin
[LiteratureReference:9652541] Glyburide: a second-generation sulfonylurea hypoglycemic agent. History, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects
modified[InstanceEdit:9652618] Jassal, Bijay, 2019-07-01
[InstanceEdit:9690266] Jassal, Bijay, 2020-05-28
[InstanceEdit:9773229] Matthews, Lisa, 2022-05-03
[InstanceEdit:9773839] Matthews, Lisa, 2022-05-10
[InstanceEdit:9773858] Matthews, Lisa, 2022-05-10
[InstanceEdit:9815564] Matthews, Lisa, 2022-08-19
[InstanceEdit:9830342] Matthews, Lisa, 2023-03-08
nameSU drugs bind ABCC8 (in KCNJ11 tetramer:ABCC8:Mg2+:ADP tetramer)
output[Complex:9652593] ABCC8:SU drugs [plasma membrane] [Homo sapiens]
releaseDate2022-06-09
reviewed[InstanceEdit:9767610] Huddart, Rachel, 2022-03-01
reviewStatus[ReviewStatus:9821382] five stars
species[Species:48887] Homo sapiens
stableIdentifier[StableIdentifier:9652608] R-HSA-9652580.3
summation[Summation:9652561] Sulfonylurea (SU) drugs represent a group of anti-hyperglyce...
(hasEvent)[Pathway:422356] Regulation of insulin secretion [Homo sapiens]
(updatedInstance)[_UpdateTracker:9864007] Update Tracker - [Reaction:9652580] SU drugs bind ABCC8 (in KCNJ11 tetramer:ABCC8:Mg2+:ADP tetramer) - v88:[modifyText]
[Change default viewing format]
No pathways have been reviewed or authored by SU drugs bind ABCC8 (in KCNJ11 tetramer:ABCC8:Mg2+:ADP tetramer) (9652580)